KEEN VISION ACQUISITION CORP (KVAC:NASDAQ)
$12.03 0.03 (0.25%)
Analysed KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) News Sources
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
15-07-2025
yahoo.com
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
24-06-2025
yahoo.com
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
13-06-2025
yahoo.com
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
19-05-2025
yahoo.com
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
12-05-2025
yahoo.com
What is the current price of KEEN VISION ACQUISITION CORP (KVAC:NASDAQ)?
The current price of KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) is $12.03.
KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) absolute price change since previous trading day?
The absolute price change of KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) since the previous trading day is $0.03.
KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) percentage price change since previous trading day?
The percentage price change of KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) since the previous trading day is 0.25%.
What is the most recent average sentiment score for KEEN VISION ACQUISITION CORP (KVAC:NASDAQ)?
The most recent average sentiment score for KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for KEEN VISION ACQUISITION CORP (KVAC:NASDAQ)?
The most recent sentiment for KEEN VISION ACQUISITION CORP (KVAC:NASDAQ) is .
SEC-8K** Filing Available For KEEN VISION ACQUISITION CORP (KVAC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.